ENTITY

CSL (CSLLY US)

3
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•28 Oct 2025 05:53

CBA, ANZ, Westpac, NAB: Volatility Runs High Ahead of Imminent Catalysts

​Implied volatility analysis reveals rich options trading in Australian banks, offering insights for traders and investors.

Logo
263 Views
Share
bearish•BHP Group Ltd
•12 Oct 2025 16:16

BHP (BHP AU/US) And Woodside (WDS AU/US) Slide as U.S. Sell-Off Spills Into Australian Stocks

Friday’s U.S. market rout pushed dual-listed Australian stocks lower, with BHP and Woodside among the biggest movers. US-traded ADRs and futures...

Logo
523 Views
Share
bullish•Macquarie Group
•06 Oct 2025 06:54

From Banks to Miners: Cheap Vs. Rich Volatility Across Australia

​Volatility cones help evaluate options trading, showing Australian banks are rich and miners are cheap in December. Spot opportunities and manage...

Logo
437 Views
Share
No more insights
x